Publicaciones en colaboración con investigadores/as de Universitat de Girona (20)

2024

  1. A two-years real-word study with fingolimod: early predictors of efficacy and an association between EBNA-1 IgG titers and multiple sclerosis progression

    Frontiers in Immunology, Vol. 15

  2. Novel risk loci for COVID-19 hospitalization among admixed American populations

    eLife, Vol. 13

  3. Role of miRNA–mRNA Interactome in Pathophysiology of Arrhythmogenic Cardiomyopathy

    Biomedicines, Vol. 12, Núm. 8

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Association of Serum Neurofilament Light Chain Levels at Disease Onset with Disability Worsening in Patients with a First Demyelinating Multiple Sclerosis Event Not Treated with High-Efficacy Drugs

    JAMA Neurology, Vol. 80, Núm. 4, pp. 397-403

  3. Evaluation of Somatic Mutations in Urine Samples as a Noninvasive Method for the Detection and Molecular Classification of Endometrial Cancer

    Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 29, Núm. 18, pp. 3681-3690

  4. Evaluation of somatic mutations in cervicovaginal samples as a non-invasive method for the detection and molecular classification of endometrial cancer

    eBioMedicine, Vol. 94

  5. Fecal carriage of extended-spectrum beta-lactamase-producing Enterobacterales in healthy Spanish schoolchildren

    Frontiers in Microbiology, Vol. 14

2022

  1. An Integrated Approach for the Early Detection of Endometrial and Ovarian Cancers (Screenwide Study): Rationale, Study Design and Pilot Study

    Journal of Personalized Medicine, Vol. 12, Núm. 7

  2. Novel genes and sex differences in COVID-19 severity

    Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806

  3. The Role of MicroRNAs in Dilated Cardiomyopathy: New Insights for an Old Entity

    International Journal of Molecular Sciences, Vol. 23, Núm. 21

  4. miR-16-5p Suppression Protects Human Cardiomyocytes against Endoplasmic Reticulum and Oxidative Stress-Induced Injury

    International Journal of Molecular Sciences, Vol. 23, Núm. 3

2021

  1. Circulating circRNA as biomarkers for dilated cardiomyopathy etiology

    Journal of Molecular Medicine, Vol. 99, Núm. 12, pp. 1711-1725

  2. Identification of the Immunological Changes Appearing in the CSF During the Early Immunosenescence Process Occurring in Multiple Sclerosis

    Frontiers in Immunology, Vol. 12

  3. Plasma microrna expression profile for reduced ejection fraction in dilated cardiomyopathy

    Scientific Reports, Vol. 11, Núm. 1

2020

  1. Peripheral microRNA panels to guide the diagnosis of familial cardiomyopathy

    Translational Research, Vol. 218, pp. 1-15

2017

  1. Familial dilated cardiomyopathy: A multidisciplinary entity, from basic screening to novel circulating biomarkers

    International Journal of Cardiology, Vol. 228, pp. 870-880

2016

  1. The utility of heart failure registries: A descriptive and comparative study of two heart failure registries

    Postgraduate Medical Journal, Vol. 92, Núm. 1087, pp. 260-266

2014

  1. Executive summary of the recommendations on the evaluation and management of renal disease in human immunodeficiency virus-infected patients

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 32, Núm. 9, pp. 583-597

  2. Resumen ejecutivo del documento de consenso sobre el manejo de la patología renal en pacientes con infección por VIH

    Nefrologia, Vol. 34, Núm. 6, pp. 768-788